 Matthew Witkowski
Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2024 | 64 | 2.860 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 | 2023 | 256 | 2.290 |
Why?
| | Lymphoma, B-Cell | 2 | 2023 | 86 | 1.580 |
Why?
| | Tumor Microenvironment | 6 | 2023 | 430 | 1.390 |
Why?
| | Ikaros Transcription Factor | 2 | 2017 | 17 | 1.040 |
Why?
| | Leukemia, Myeloid, Acute | 6 | 2023 | 534 | 1.020 |
Why?
| | Bone Marrow | 4 | 2022 | 243 | 0.980 |
Why?
| | Leukemia | 3 | 2022 | 209 | 0.900 |
Why?
| | Burkitt Lymphoma | 1 | 2022 | 52 | 0.800 |
Why?
| | Monocytes | 2 | 2023 | 502 | 0.750 |
Why?
| | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2021 | 16 | 0.680 |
Why?
| | Immunity | 1 | 2019 | 121 | 0.630 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2019 | 152 | 0.580 |
Why?
| | Immunotherapy | 2 | 2022 | 474 | 0.550 |
Why?
| | Receptors, Notch | 2 | 2019 | 84 | 0.500 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2020 | 858 | 0.490 |
Why?
| | F-Box Proteins | 1 | 2015 | 20 | 0.480 |
Why?
| | Immunotherapy, Adoptive | 3 | 2022 | 183 | 0.480 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2015 | 139 | 0.450 |
Why?
| | Stem Cell Niche | 3 | 2020 | 42 | 0.370 |
Why?
| | Cell Cycle Proteins | 1 | 2015 | 551 | 0.370 |
Why?
| | Single-Cell Analysis | 3 | 2023 | 188 | 0.340 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1040 | 0.310 |
Why?
| | Trans-Activators | 2 | 2022 | 367 | 0.310 |
Why?
| | T-Lymphocytes | 4 | 2022 | 1736 | 0.310 |
Why?
| | Animals | 13 | 2024 | 31692 | 0.290 |
Why?
| | Flow Cytometry | 2 | 2023 | 1083 | 0.260 |
Why?
| | Hematopoietic Stem Cells | 2 | 2019 | 343 | 0.260 |
Why?
| | Antigens, CD19 | 2 | 2022 | 91 | 0.250 |
Why?
| | Proto-Oncogene Proteins | 2 | 2019 | 608 | 0.240 |
Why?
| | Lymphopoiesis | 1 | 2024 | 24 | 0.230 |
Why?
| | Mice | 10 | 2021 | 14859 | 0.230 |
Why?
| | Cell Differentiation | 4 | 2021 | 1699 | 0.220 |
Why?
| | Humans | 20 | 2024 | 114616 | 0.220 |
Why?
| | Cleavage And Polyadenylation Specificity Factor | 1 | 2022 | 7 | 0.210 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2023 | 100 | 0.200 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2023 | 88 | 0.200 |
Why?
| | Osteoblasts | 2 | 2020 | 106 | 0.200 |
Why?
| | Polyadenylation | 1 | 2022 | 37 | 0.200 |
Why?
| | Valine-tRNA Ligase | 1 | 2021 | 1 | 0.200 |
Why?
| | Phospholipase C gamma | 1 | 2022 | 26 | 0.200 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2024 | 308 | 0.200 |
Why?
| | Hematopoiesis | 2 | 2021 | 171 | 0.190 |
Why?
| | Valine | 1 | 2021 | 72 | 0.190 |
Why?
| | Adipocytes | 2 | 2020 | 188 | 0.190 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 56 | 0.190 |
Why?
| | Hematologic Neoplasms | 1 | 2023 | 137 | 0.190 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2022 | 636 | 0.180 |
Why?
| | Antigens, Surface | 1 | 2021 | 146 | 0.180 |
Why?
| | Membrane Glycoproteins | 1 | 2022 | 430 | 0.180 |
Why?
| | Mutation | 3 | 2022 | 3344 | 0.170 |
Why?
| | Cell Transdifferentiation | 1 | 2019 | 31 | 0.160 |
Why?
| | Bone Marrow Transplantation | 1 | 2020 | 239 | 0.160 |
Why?
| | Cellular Microenvironment | 1 | 2019 | 78 | 0.150 |
Why?
| | Signal Transduction | 4 | 2022 | 4509 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2019 | 316 | 0.150 |
Why?
| | Catenins | 1 | 2017 | 5 | 0.140 |
Why?
| | Ascorbic Acid | 1 | 2017 | 110 | 0.140 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2017 | 61 | 0.140 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 347 | 0.140 |
Why?
| | Proteome | 1 | 2020 | 338 | 0.140 |
Why?
| | Endothelium, Vascular | 2 | 2020 | 843 | 0.140 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 13 | 0.130 |
Why?
| | bcl-X Protein | 1 | 2016 | 38 | 0.130 |
Why?
| | Protein Kinase Inhibitors | 1 | 2022 | 785 | 0.130 |
Why?
| | Vitamins | 1 | 2017 | 151 | 0.130 |
Why?
| | Prognosis | 2 | 2023 | 3328 | 0.130 |
Why?
| | Survival Rate | 1 | 2020 | 1644 | 0.130 |
Why?
| | Myelodysplastic Syndromes | 1 | 2017 | 119 | 0.130 |
Why?
| | Repressor Proteins | 1 | 2019 | 366 | 0.130 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 329 | 0.130 |
Why?
| | Cell Line, Tumor | 3 | 2017 | 2710 | 0.130 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2019 | 615 | 0.130 |
Why?
| | Homeodomain Proteins | 1 | 2019 | 463 | 0.120 |
Why?
| | F-Box-WD Repeat-Containing Protein 7 | 1 | 2015 | 6 | 0.120 |
Why?
| | RNA, Messenger | 1 | 2022 | 2552 | 0.120 |
Why?
| | Receptors, Cell Surface | 1 | 2017 | 355 | 0.120 |
Why?
| | B-Lymphocytes | 1 | 2020 | 766 | 0.120 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 128 | 0.120 |
Why?
| | PAX5 Transcription Factor | 1 | 2014 | 12 | 0.120 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2014 | 34 | 0.110 |
Why?
| | RNA-Binding Proteins | 1 | 2017 | 344 | 0.110 |
Why?
| | Neoplasm Proteins | 1 | 2017 | 384 | 0.110 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 4689 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2020 | 3001 | 0.110 |
Why?
| | Blood Platelets | 1 | 2016 | 351 | 0.110 |
Why?
| | Mice, Transgenic | 2 | 2015 | 1947 | 0.110 |
Why?
| | Blotting, Western | 1 | 2015 | 1147 | 0.100 |
Why?
| | Antineoplastic Agents | 2 | 2020 | 1879 | 0.100 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 439 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2017 | 1018 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2017 | 1313 | 0.090 |
Why?
| | Carcinogenesis | 2 | 2019 | 177 | 0.070 |
Why?
| | Infant | 1 | 2020 | 7954 | 0.070 |
Why?
| | Apoptosis | 1 | 2016 | 2362 | 0.070 |
Why?
| | Child, Preschool | 1 | 2020 | 9106 | 0.070 |
Why?
| | Child | 2 | 2022 | 18402 | 0.060 |
Why?
| | Young Adult | 1 | 2020 | 10455 | 0.060 |
Why?
| | Gene Knockdown Techniques | 2 | 2017 | 299 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2020 | 12542 | 0.060 |
Why?
| | Adult | 2 | 2022 | 30528 | 0.050 |
Why?
| | Oncogenes | 1 | 2023 | 103 | 0.050 |
Why?
| | Adolescent | 1 | 2020 | 17830 | 0.050 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2021 | 15 | 0.050 |
Why?
| | Electron Transport Complex I | 1 | 2021 | 33 | 0.050 |
Why?
| | Biological Availability | 1 | 2021 | 119 | 0.050 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2022 | 107 | 0.050 |
Why?
| | Lymphocytes | 1 | 2023 | 330 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2023 | 337 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2021 | 78 | 0.050 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 155 | 0.050 |
Why?
| | RNA, Transfer | 1 | 2021 | 118 | 0.050 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2021 | 25 | 0.050 |
Why?
| | Lab-On-A-Chip Devices | 1 | 2020 | 30 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 213 | 0.050 |
Why?
| | Piperidines | 1 | 2022 | 160 | 0.040 |
Why?
| | Adenine | 1 | 2022 | 219 | 0.040 |
Why?
| | Acute Disease | 1 | 2023 | 910 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2022 | 339 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2319 | 0.040 |
Why?
| | Recurrence | 1 | 2022 | 935 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 385 | 0.040 |
Why?
| | Chromatin | 1 | 2023 | 428 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2019 | 3881 | 0.040 |
Why?
| | Cell Plasticity | 1 | 2019 | 23 | 0.040 |
Why?
| | Receptors, Interferon | 1 | 2019 | 47 | 0.040 |
Why?
| | Tretinoin | 1 | 2019 | 122 | 0.040 |
Why?
| | Myeloid Cells | 1 | 2019 | 126 | 0.040 |
Why?
| | Male | 2 | 2020 | 55549 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2019 | 206 | 0.040 |
Why?
| | Dioxygenases | 1 | 2017 | 25 | 0.040 |
Why?
| | Cell Lineage | 1 | 2019 | 309 | 0.040 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2017 | 40 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2017 | 181 | 0.040 |
Why?
| | Female | 2 | 2020 | 59461 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2017 | 228 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2019 | 282 | 0.030 |
Why?
| | Mitochondria | 1 | 2021 | 747 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 367 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2019 | 378 | 0.030 |
Why?
| | Cell Death | 1 | 2017 | 322 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1527 | 0.030 |
Why?
| | Protein Domains | 1 | 2016 | 206 | 0.030 |
Why?
| | Diet | 1 | 2021 | 1080 | 0.030 |
Why?
| | Genes, myc | 1 | 2014 | 46 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2014 | 44 | 0.030 |
Why?
| | Risk Assessment | 1 | 2022 | 2967 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 724 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 805 | 0.030 |
Why?
| | DNA Methylation | 1 | 2017 | 495 | 0.030 |
Why?
| | Cell Survival | 1 | 2016 | 1020 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2019 | 2565 | 0.030 |
Why?
| | Inflammation | 1 | 2022 | 2477 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2017 | 1313 | 0.020 |
Why?
| | Protein Binding | 1 | 2016 | 1888 | 0.020 |
Why?
| | Cell Line | 1 | 2016 | 2635 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2014 | 1141 | 0.020 |
Why?
| | Middle Aged | 1 | 2022 | 26719 | 0.010 |
Why?
|
|
Witkowski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|